Transformative Therapies for Autoimmune Diseases
LinkedIn
Twitter
Svenska
About
About Cyxone
Management
Board of Directors
Scientific Advisory Board
Therapy Areas
Autoimmune and Autoinflammatory Diseases
Rheumatoid Arthritis
Multiple Sclerosis
Pipeline
Our Projects
Rabeximod
T20K
Intellectual Property
Investors
Investor Relations
Share information
Owners
Financial Reports
Financial Calendar
Share issues
Analysts
Corporate governance
General Meetings
News
News
Press Releases
Cyxone in media
Company Presentations
Events
Company Presentations
About
About Cyxone
Management
Board of Directors
Scientific Advisory Board
Therapy Areas
Autoimmune and Autoinflammatory Diseases
Rheumatoid Arthritis
Multiple Sclerosis
Pipeline
Our Projects
Rabeximod
T20K
Intellectual Property
Investors
Investor Relations
Share information
Owners
Financial Reports
Financial Calendar
Share issues
Analysts
Corporate governance
General Meetings
News
News
Press Releases
Cyxone in media
Company Presentations
Events
Company Presentations
Follow the latest company presentations and video interviews on this page.
BioStock: Interview with CEO Kjell Stenberg (in swedish)
2024-07-23
Archive
2024
BioStock: Interview with CEO Kjell Stenberg (in swedish)
2024-07-23
BioStock: Interview with CEO Kjell Stenberg (in swedish)
2024-05-28
BioStock: Interview with CEO Carl-Magnus Högerkorp (in swedish)
2024-01-22
2023
BioStock interview
2023-11-15
BioStock Life Science Summit
2023-10-25
BioStock Investor Meeting
2023-09-20
BioStock Investor Meeting: Interview with CEO Carl-Magnus Högerkorp
2023-09-20
Erik Penser Healthcare Day (in swedish)
2023-09-07
Erik Penser: Interview with CEO Carl-Magnus Högerkorp
2023-09-04
BioStock studio: Interview with CEO Carl-Magnus Högerkorp
2023-08-31
Penserpodden – company pitch with Cyxone
2023-08-31
BioStock Studio: An update from the chairman of the board and CEO of Cyxone (Only in Swedish)
2023-06-02
2022
BioStock Studio: Cyxone’s CEO on the current state and the pipeline
2022-12-14
BioStock Life Science Fall Summit 2022
2022-11-30
BioStock Studio: Cyxone on the phase IIb study
2022-10-13
NLSDays
2022-09-28
Biostock Investor Meeting
2022-09-14
HC Andersen Capital’s online event
2022-04-29
Redeye Investor Forum March 3, 2022
2022-03-03
Aktiedagen Lund, January 31 2022
2022-01-31
Redeye Investor Forum 2022
2022-01-13
2021
Redeye: Interview with CEO Tara Heitner
2021-12-08
BioStock Studio: Cyxone comments on the Covid-19 study result
2021-12-08
Aktieportföljen
2021-11-24
Redeye Life Science Day 2021
2021-11-11
Kvinnokvällen, Malmö October 19 2021
2021-10-19
Vator Securities Healthcare Innovation Summit
2021-10-07
Redeye Investment Forum 2021, Malmö
2021-09-30
Redeye: Interview with CEO Tara Heitner
2021-09-02
Redeye Growth Day 2021
2021-06-02
BioStock Life Science Spring Summit 2021
2021-05-31
Redeye Investor Forum online April 29 2021
2021-04-29
Mangold Insights Investor Breakfast April 7 2021
2021-04-07
BioStock Live March 9 2021
2021-03-09
Aktiedagen Lund January 27 2021
2021-01-27
2020
BioStock Life Science Summit 2020
2020-11-18
Interview with CEO Tara Heitner September 15, 2020
2020-09-15
2018
Småbolagsjakten Live (in swedish)
2018-11-14
Analyst Group interviews CEO Kjell G Stenberg (in swedish)
2018-10-12
Cyxone Presentation – BioStock Live (in swedish)
2018-02-28
Cyxone Interview – BioStock Live (in swedish)
2018-02-28
2017
CEO Kjell Stenberg presents Cyxone at BioStock Live in Stockholm (in swedish)
2017-09-28
We only use cookies that are necessary for the function of the website. No cookies are used for analysis or marketing purpose.
Accept
Manage consent
Close
Cookies
Vi placerar inga analys- eller marknadsföringscookies utan enbart cookies som är nödvändiga för hemsidans funktion.